Matt OBrien

Stock Analyst at Piper Sandler

(3.01)
# 1,463
Out of 5,041 analysts
8
Total ratings
87.5%
Success rate
40.53%
Average return

Stocks Rated by Matt OBrien

HeartFlow
Sep 2, 2025
Initiates: Overweight
Price Target: $38
Current: $40.79
Upside: -6.84%
Merit Medical Systems
Oct 29, 2020
Maintains: Overweight
Price Target: $55$62
Current: $82.93
Upside: -25.24%
Tandem Diabetes Care
Feb 25, 2020
Maintains: Overweight
Price Target: $70$90
Current: $15.00
Upside: +500.00%